Q4 2024 Earnings Call Transcript February 7, 2025 Iterum Therapeutics plc beats earnings expectations. Reported EPS is $-0.12 ...
Hosted on MSN20h
Iterum Therapeutics Highlights FDA Approval and Market PotentialIterum Therapeutics (($ITRM)) has held its Q4 earnings call. Read on for the main highlights of the call. During Iterum Therapeutics’ latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback